Clinical Trial Update: A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

View source ↗

Summary

This update notes the termination of a prospective observational study evaluating the PaQ insulin delivery system in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PaQ Insulin Delivery System

Snippet

Sponsor: CeQur Corporation | Conditions: Type 2 Diabetes Mellitus | Status: TERMINATED